📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for SVA.
💹 Market Data
Market CapN/A
Shares Outstanding99.29M
FloatN/A
Cash$9.95B
Debt$379.08M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 0.1% shares (2025Q4 vs prior)
28 institutional holders · 10.50M shares
#1
Vivo Capital, LLC
5.90M shares
#2
ORBIMED ADVISORS LLC
2.72M shares
#3
RENAISSANCE TECHNOLOGIES LLC
1.31M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest82.8K
Days to Cover1000.0
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2015
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SVA
📊 SVA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SVA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.